Daver, Naval <br/><br/>
Cotargeting BCL-2 and BCL-XL for maximal efficacy in ALL.  [electronic resource] 

 -  Blood  09 2016 
 - 1316-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2016-07-724948  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>Humans<br/>Proto-Oncogene Proteins c-bcl-2<br/>bcl-X Protein